Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
EOLS compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
EOLS
Evolus, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
EOLS
Evolus, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
EOLS: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only EOLS
3
—
Daewoong Pharmaceuticals
unlisted
supplier
—
Symatese
unlisted
supplier
—
Symatese Aesthetics S.A.S
unlisted
supplier
Shared
0
No shared counterparties.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
25 more · LLY chain
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
EOLS, solid
LLY, dashed
EOLS
Evolus, Inc.
Change
6.84
▲
+0.70%
Mkt cap
$449.7M
Revenue
$78M
Q3 FY26
Revenue
$297M
FY25
LLY
ELI Lilly & Co
Change
1,361.88
▼
−0.21%
Regular session
Nov 6 '26
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Regular session
Nov 6 '26
EOLS
Evolus, Inc.
vs
LLY
ELI Lilly & Co
6.84
▲
+0.70%
Price
1,361.88
▼
−0.21%
$449.7M
Mkt cap
$1.2T
Q3 FY26
$78M
Revenue
$24.4B
Q3 FY26
FY25
$297M
Revenue
$65.2B
FY25
Change
Change
EOLS
6.84
▲
+0.70%
vs
LLY
1,361.88
▼
−0.21%
Regular session
Nov 6 '26